Skip to main content
Top
Published in: Nutrition & Metabolism 1/2017

Open Access 01-12-2017 | Review

Do metabolic syndrome and its components have an impact on bone mineral density in adolescents?

Authors: Valéria Nóbrega da Silva, Luciana Nunes Mosca Fiorelli, Carla Cristiane da Silva, Cilmery Suemi Kurokawa, Tamara Beres Lederer Goldberg

Published in: Nutrition & Metabolism | Issue 1/2017

Login to get access

Abstract

In recent years, there has been growing concern about the occurrence of metabolic syndrome (MetS) at an early age and its effects on bone mass in adolescents. Adolescence is considered a critical period for bone mass gain. Impaired bone acquisition during this phase can lead to “suboptimal” peak bone mass and increase the risk of osteopenia/osteoporosis and fractures in old age. The objective of this review was to perform a critical analysis of articles that specifically focus on this age group, evaluating the influence of MetS and its components on bone mineral density in adolescents. A possible relationship between this syndrome and bone mass has been demonstrated, but the number of studies addressing this topic in adolescents is small. Despite the scarcity of evidence, the results of those studies show that Metabolic Syndrome is negatively correlated with bone mass and also that some components of MetS are negatively correlated with bone mineral density in adolescents. However, the associations between MetS and bone mass development need to be further explored in the age group corresponding to adolescence. Further good-quality studies are necessary to complement the understanding of this relationship.
Literature
1.
go back to reference Zimmet P, Alberti KGMM, Kaufman F, IDF Consensus Group, et al. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatr Diabetes. 2007;8:299–306.CrossRefPubMed Zimmet P, Alberti KGMM, Kaufman F, IDF Consensus Group, et al. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatr Diabetes. 2007;8:299–306.CrossRefPubMed
2.
go back to reference Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009;119:628–47.CrossRefPubMed Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2009;119:628–47.CrossRefPubMed
3.
go back to reference Kim HY, Choe JW, Kim HK, et al. Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men. Calcif Tissue Int. 2010;86:350–8.CrossRefPubMed Kim HY, Choe JW, Kim HK, et al. Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men. Calcif Tissue Int. 2010;86:350–8.CrossRefPubMed
5.
go back to reference Lawlor DA, Sattar N, Sayers A, et al. The association of fasting insulin, glucose, and lipids with bone mass in adolescents: findings from a cross-sectional study. J Clin Endocrinol Metab. 2012;97:2068–76.CrossRefPubMedPubMedCentral Lawlor DA, Sattar N, Sayers A, et al. The association of fasting insulin, glucose, and lipids with bone mass in adolescents: findings from a cross-sectional study. J Clin Endocrinol Metab. 2012;97:2068–76.CrossRefPubMedPubMedCentral
6.
go back to reference Kim T, Park S, Pak YS, et al. Association between metabolic syndrome and bone mineral density in Korea: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008. J Bone Miner Metab. 2013;1:1–11.CrossRef Kim T, Park S, Pak YS, et al. Association between metabolic syndrome and bone mineral density in Korea: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008. J Bone Miner Metab. 2013;1:1–11.CrossRef
7.
go back to reference Nóbrega VS, Goldberg TB, Mosca LN, et al. Metabolic syndrome reduces bone mineral density in overweight adolescents. Bone. 2014;66:1–7.CrossRef Nóbrega VS, Goldberg TB, Mosca LN, et al. Metabolic syndrome reduces bone mineral density in overweight adolescents. Bone. 2014;66:1–7.CrossRef
8.
go back to reference Hwang DK, Choi HJ. The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos Int. 2010;21:425–31.CrossRefPubMed Hwang DK, Choi HJ. The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos Int. 2010;21:425–31.CrossRefPubMed
9.
go back to reference Szulc P, Varennes A, Delmas PD, et al. Men with metabolic syndrome have lower bone mineral density but lower fracture risk—the MINOS study. J Bone Miner Res. 2010;25:446–1454.CrossRef Szulc P, Varennes A, Delmas PD, et al. Men with metabolic syndrome have lower bone mineral density but lower fracture risk—the MINOS study. J Bone Miner Res. 2010;25:446–1454.CrossRef
10.
go back to reference Esposito K, Chiodini P, Capuano A, et al. Fracture risk and bone mineral density in metabolic syndrome: a meta-analysis. J Clin Endocrinol Metab. 2013;98:3306–14.CrossRefPubMed Esposito K, Chiodini P, Capuano A, et al. Fracture risk and bone mineral density in metabolic syndrome: a meta-analysis. J Clin Endocrinol Metab. 2013;98:3306–14.CrossRefPubMed
11.
go back to reference Muka T, Trajanoska K, Kiefte-de Jong JC, Oei L, Uitterlinden AG, Hofman A, et al. The Association between metabolic syndrome, bone mineral density, hip bone geometry and fracture risk: the Rotterdam study. PLoS One. 2015;6:1–15. Muka T, Trajanoska K, Kiefte-de Jong JC, Oei L, Uitterlinden AG, Hofman A, et al. The Association between metabolic syndrome, bone mineral density, hip bone geometry and fracture risk: the Rotterdam study. PLoS One. 2015;6:1–15.
12.
go back to reference Boot AM, Ridder MA, Van der Sluis IM, et al. Peak bone mineral density, lean body mass and fractures. Bone. 2010;46:336–41.CrossRefPubMed Boot AM, Ridder MA, Van der Sluis IM, et al. Peak bone mineral density, lean body mass and fractures. Bone. 2010;46:336–41.CrossRefPubMed
13.
go back to reference Rizzoli R, Bianchi ML, Garabédian M, et al. Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone. 2010;46:294–305.CrossRefPubMed Rizzoli R, Bianchi ML, Garabédian M, et al. Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone. 2010;46:294–305.CrossRefPubMed
14.
go back to reference Lee K. Sex-specific relationships between insulin resistance and bone mineral content in Korean adolescents. J Bone Miner Metab. 2013;31:177–82.CrossRefPubMed Lee K. Sex-specific relationships between insulin resistance and bone mineral content in Korean adolescents. J Bone Miner Metab. 2013;31:177–82.CrossRefPubMed
15.
go back to reference Afghani A, Cruz ML, Goran MI. Impaired glucose tolerance and bone mineral content in overweight Latino children with a family history of type 2 diabetes. Diabetes Care. 2005;28:372–8.CrossRefPubMed Afghani A, Cruz ML, Goran MI. Impaired glucose tolerance and bone mineral content in overweight Latino children with a family history of type 2 diabetes. Diabetes Care. 2005;28:372–8.CrossRefPubMed
16.
17.
go back to reference Kalkwarf HJ. Adiposity and bone: the influence of subcutaneous versus visceral fat and insulin resistance. J Pediatr. 2011;158:698–700.CrossRefPubMed Kalkwarf HJ. Adiposity and bone: the influence of subcutaneous versus visceral fat and insulin resistance. J Pediatr. 2011;158:698–700.CrossRefPubMed
18.
go back to reference Mosca LN, Goldberg LTB, Nóbrega VS, et al. Excess body fat negatively affects bone mass in adolescents. Nutrition. 2014;30:847–52.CrossRefPubMed Mosca LN, Goldberg LTB, Nóbrega VS, et al. Excess body fat negatively affects bone mass in adolescents. Nutrition. 2014;30:847–52.CrossRefPubMed
19.
go back to reference Rizzo AC, Goldberg TB, Silva CC, et al. Metabolic syndrome risk factors in overweight, obese, and extremely obese Brazilian adolescents. Nutr J. 2013;30:12–9. Rizzo AC, Goldberg TB, Silva CC, et al. Metabolic syndrome risk factors in overweight, obese, and extremely obese Brazilian adolescents. Nutr J. 2013;30:12–9.
20.
go back to reference Lavet C, Martin A, Linossier M, Bossche AV, Laroche N, Thomas M, Gerbaix M, Ammann P, Fraissenon A, Lafage-Proust MH, Courteix D, Vico L. Metabolism disturbances:kinetic and reversibility studies in growing and adults rats. J Bone Miner Res. 2016;31:98–115.CrossRefPubMed Lavet C, Martin A, Linossier M, Bossche AV, Laroche N, Thomas M, Gerbaix M, Ammann P, Fraissenon A, Lafage-Proust MH, Courteix D, Vico L. Metabolism disturbances:kinetic and reversibility studies in growing and adults rats. J Bone Miner Res. 2016;31:98–115.CrossRefPubMed
21.
22.
go back to reference Silva CC, Goldberg TBL, Teixeira AS, et al. Mineralização óssea em adolescentes do sexo masculino: anos críticos para a aquisição da massa óssea. J Pediatr. 2004;80:461–7.CrossRef Silva CC, Goldberg TBL, Teixeira AS, et al. Mineralização óssea em adolescentes do sexo masculino: anos críticos para a aquisição da massa óssea. J Pediatr. 2004;80:461–7.CrossRef
23.
go back to reference Bonjour JP, Chevalley T, Ferrari S, et al. The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex. 2009;51:S5–17.CrossRefPubMed Bonjour JP, Chevalley T, Ferrari S, et al. The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex. 2009;51:S5–17.CrossRefPubMed
24.
go back to reference Moretto MR, Silva CC, Kurokawa CS, et al. Bone mineral density in healthy female adolescents according to age, bone age and pubertal breast stage. Open Orthop J. 2011;5:324–30.CrossRefPubMedCentral Moretto MR, Silva CC, Kurokawa CS, et al. Bone mineral density in healthy female adolescents according to age, bone age and pubertal breast stage. Open Orthop J. 2011;5:324–30.CrossRefPubMedCentral
25.
go back to reference Campos LMA, Liphaus BL, Silva CAA, et al. Osteoporose na infância e adolescência. J Pediatr (Rio J). 2003;79:481–8. Campos LMA, Liphaus BL, Silva CAA, et al. Osteoporose na infância e adolescência. J Pediatr (Rio J). 2003;79:481–8.
26.
go back to reference Bailey DA, Martin AD, McKay HA, et al. Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res. 2000;15:2245–50.CrossRefPubMed Bailey DA, Martin AD, McKay HA, et al. Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res. 2000;15:2245–50.CrossRefPubMed
27.
go back to reference Goulding A, Grant AM, Williams SM. Bone and body composition of children and adolescents with repeated forearm fractures. J Bone Miner Res. 2005;20:2090–6.CrossRefPubMed Goulding A, Grant AM, Williams SM. Bone and body composition of children and adolescents with repeated forearm fractures. J Bone Miner Res. 2005;20:2090–6.CrossRefPubMed
28.
go back to reference Vargas DM, Rigotti T, Gütz CNRM, et al. Mineralização óssea em crianças com diabetes melito tipo1. J Pediatr (Rio J). 2003;79:253–7. Vargas DM, Rigotti T, Gütz CNRM, et al. Mineralização óssea em crianças com diabetes melito tipo1. J Pediatr (Rio J). 2003;79:253–7.
29.
go back to reference Goldberg TBL, Silva CC, Hong SN, et al. Bone biomarkers and bone mineral density in healthy male adolescents: Impact of biological maturation. Acta Paediatrica. 2009;98(Suppl S460):146. Goldberg TBL, Silva CC, Hong SN, et al. Bone biomarkers and bone mineral density in healthy male adolescents: Impact of biological maturation. Acta Paediatrica. 2009;98(Suppl S460):146.
30.
go back to reference Bachrach LK, Sills IN. Section on endocrinology. Clinical report-bone densitometry in children and adolescents. Pediatrics. 2011;127:189–94.CrossRefPubMed Bachrach LK, Sills IN. Section on endocrinology. Clinical report-bone densitometry in children and adolescents. Pediatrics. 2011;127:189–94.CrossRefPubMed
32.
go back to reference Russell M, Mendes N, Miller KK, et al. Adolescent girls visceral fat is a negative predictor of bone density measures in obese. J Clin Endocrinol Metab. 2010;95:1247–55.CrossRefPubMedPubMedCentral Russell M, Mendes N, Miller KK, et al. Adolescent girls visceral fat is a negative predictor of bone density measures in obese. J Clin Endocrinol Metab. 2010;95:1247–55.CrossRefPubMedPubMedCentral
33.
go back to reference Júnior IF, Cardoso JR, Christofaro DG, et al. The relationship between visceral fat thickness and bone mineral density in sedentary obese children andadolescents. BMC Pediatr. 2013;20:13–37. Júnior IF, Cardoso JR, Christofaro DG, et al. The relationship between visceral fat thickness and bone mineral density in sedentary obese children andadolescents. BMC Pediatr. 2013;20:13–37.
34.
go back to reference Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939–49.CrossRefPubMed Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939–49.CrossRefPubMed
35.
go back to reference Magni P, Dozio E, Galliera E, et al. Molecular aspects of adipokine-bone. Curr Mol Med. 2010;10:522–32.PubMed Magni P, Dozio E, Galliera E, et al. Molecular aspects of adipokine-bone. Curr Mol Med. 2010;10:522–32.PubMed
36.
go back to reference Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009;94:827–32.CrossRefPubMed Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009;94:827–32.CrossRefPubMed
37.
go back to reference Bae SJ, Choe JW, Chung YE, Kim BJ, Lee SH, Kim HY, et al. The association between serum osteocalcin levels and metabolic syndrome in Koreans. Osteoporos Int. 2011;22:2837–46.CrossRefPubMed Bae SJ, Choe JW, Chung YE, Kim BJ, Lee SH, Kim HY, et al. The association between serum osteocalcin levels and metabolic syndrome in Koreans. Osteoporos Int. 2011;22:2837–46.CrossRefPubMed
38.
go back to reference Reinehr T, Roth CL. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes (Lond). 2010;34:852–8.CrossRef Reinehr T, Roth CL. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes (Lond). 2010;34:852–8.CrossRef
39.
go back to reference Kim GS, Jekal Y, Kim HS, Im JA, Park JY, Chu SH. Reduced serum total osteocalcin is associated with central obesity in Korean children. Obes Res Clin Pract. 2013;8:230–37.CrossRef Kim GS, Jekal Y, Kim HS, Im JA, Park JY, Chu SH. Reduced serum total osteocalcin is associated with central obesity in Korean children. Obes Res Clin Pract. 2013;8:230–37.CrossRef
40.
go back to reference Dimitri P, Wales JK, Bishop N. Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. Bone. 2011;48:189–96.CrossRefPubMed Dimitri P, Wales JK, Bishop N. Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. Bone. 2011;48:189–96.CrossRefPubMed
41.
go back to reference Dimitri P, Jacques RM, Paggiosi M, King D, Walsh J, Taylor ZA, et al. Leptin may play a role in bone microstructural alterations in obese children. J Clin Endocrinol Metab. 2014;100:594–602.CrossRefPubMedPubMedCentral Dimitri P, Jacques RM, Paggiosi M, King D, Walsh J, Taylor ZA, et al. Leptin may play a role in bone microstructural alterations in obese children. J Clin Endocrinol Metab. 2014;100:594–602.CrossRefPubMedPubMedCentral
42.
go back to reference Lee NK, Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab. 2008;19:161–66.CrossRefPubMed Lee NK, Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab. 2008;19:161–66.CrossRefPubMed
43.
go back to reference Foo JP, Polyzos SA, Anastasilakis AD, Chou S, Mantzoros CS. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. J Clin Endocrinol Metab. 2014;99:E2252–8.CrossRefPubMed Foo JP, Polyzos SA, Anastasilakis AD, Chou S, Mantzoros CS. The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea. J Clin Endocrinol Metab. 2014;99:E2252–8.CrossRefPubMed
44.
go back to reference McFarlane SI. Bone metabolism and the cardiometabolic syndrome: pathophysiologic insights. J Cardiometab Syndr. 2006;1:53–7.CrossRefPubMed McFarlane SI. Bone metabolism and the cardiometabolic syndrome: pathophysiologic insights. J Cardiometab Syndr. 2006;1:53–7.CrossRefPubMed
45.
go back to reference Abramowicz P, Konstantynowicz J, Bialokoz-Kalinowska L, et al. High cholesterol levels may be associated with an increased osteoporosis risk in obese girls. Bone. 2009;45:S85.CrossRef Abramowicz P, Konstantynowicz J, Bialokoz-Kalinowska L, et al. High cholesterol levels may be associated with an increased osteoporosis risk in obese girls. Bone. 2009;45:S85.CrossRef
46.
go back to reference Bredella MA, Gill CM, Gerweck AV, et al. Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity. Radiology. 2013;269:534–41.CrossRefPubMedPubMedCentral Bredella MA, Gill CM, Gerweck AV, et al. Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity. Radiology. 2013;269:534–41.CrossRefPubMedPubMedCentral
47.
go back to reference Perez-Castrillon JL, Justo I, Silva J, et al. Bone mass and bone modelling markers in hypertensive postmenopausal women. J Hum Hypertens. 2003;17:107–10.CrossRefPubMed Perez-Castrillon JL, Justo I, Silva J, et al. Bone mass and bone modelling markers in hypertensive postmenopausal women. J Hum Hypertens. 2003;17:107–10.CrossRefPubMed
48.
go back to reference Bahtiyar G, Farag A, Guber H, et al. Assessment of hypertension as a risk factor for low bone mineral density in elderly men. J Clin Densitom. 2005;8:40. Bahtiyar G, Farag A, Guber H, et al. Assessment of hypertension as a risk factor for low bone mineral density in elderly men. J Clin Densitom. 2005;8:40.
49.
go back to reference Pludowski P, Litwin M, Sladowska J, et al. Bone mass and body composition in children and adolescents with primary hypertension: preliminary data. Hypertension. 2008;51:77–83.CrossRefPubMed Pludowski P, Litwin M, Sladowska J, et al. Bone mass and body composition in children and adolescents with primary hypertension: preliminary data. Hypertension. 2008;51:77–83.CrossRefPubMed
50.
go back to reference Afghani A, Goran MI. Lower bone mineral content in hypertensive compared with normotensive overweight Latino children and adolescents. Am J Hypertens. 2007;20:190–6.CrossRefPubMedPubMedCentral Afghani A, Goran MI. Lower bone mineral content in hypertensive compared with normotensive overweight Latino children and adolescents. Am J Hypertens. 2007;20:190–6.CrossRefPubMedPubMedCentral
51.
Metadata
Title
Do metabolic syndrome and its components have an impact on bone mineral density in adolescents?
Authors
Valéria Nóbrega da Silva
Luciana Nunes Mosca Fiorelli
Carla Cristiane da Silva
Cilmery Suemi Kurokawa
Tamara Beres Lederer Goldberg
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2017
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/s12986-016-0156-0

Other articles of this Issue 1/2017

Nutrition & Metabolism 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine